Karin Hoogendoorn
Directeur/Membre du Conseil chez Centre For Advanced Medical Products
Profil
Karin Hoogendoorn is currently a Director at the Centre For Advanced Medical Products.
Previously, she worked as an Associate Director at Novartis AG and Janssen Biologics BV.
She also served as a Director at Idogen AB and an Independent Director at Elicera Therapeutics AB.
Additionally, she was the Head of Chemistry, Manufacturing & Controls at Mendus AB.
Dr. Hoogendoorn holds a graduate degree from the University of Leiden and a doctorate degree from the University of Utrecht.
Postes actifs de Karin Hoogendoorn
| Sociétés | Poste | Début |
|---|---|---|
| Centre For Advanced Medical Products | Directeur/Membre du Conseil | - |
Anciens postes connus de Karin Hoogendoorn
| Sociétés | Poste | Fin |
|---|---|---|
| IDOGEN AB (PUBL) | Directeur/Membre du Conseil | 12/05/2020 |
| ELICERA THERAPEUTICS AB | Directeur/Membre du Conseil | - |
Janssen Biologics BV
 Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands. | Corporate Officer/Principal | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
| MENDUS AB | Corporate Officer/Principal | - |
Formation de Karin Hoogendoorn
| University of Leiden | Graduate Degree |
| University of Utrecht | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| NOVARTIS AG | Health Technology |
| MENDUS AB | Health Technology |
| IDOGEN AB (PUBL) | Health Technology |
| ELICERA THERAPEUTICS AB | Health Technology |
| Entreprise privées | 2 |
|---|---|
Janssen Biologics BV
Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands. | Health Technology |
| Centre For Advanced Medical Products |